Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions

Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation

(2012) Martina M. Hughes et al.   BRAIN BEHAVIOR AND IMMUNITY

Depressive and anxiety disorders in chronic hepatitis C patients: Reliability and validity of the Patient Health Questionnaire

(2012) R. Navinés et al.   JOURNAL OF AFFECTIVE DISORDERS

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement

(2012) Martin Schaefer et al.   JOURNAL OF HEPATOLOGY

Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis

(2012) Savino Bruno et al.   JOURNAL OF HEPATOLOGY

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C

(2011) R. J. de Knegt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Screening inventories to detect depression in chronic hepatitis C patients

(2011) Bruno Cópio Fábregas et al.   GENERAL HOSPITAL PSYCHIATRY

Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C patients

(2011) Yasuji Arase et al.   INTERNAL MEDICINE

Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder

(2011) Mitsuhiro Kamata et al.   JOURNAL OF AFFECTIVE DISORDERS

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

(2011) Eiichi Ogawa et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

5 REALIZE TRIAL FINAL RESULTS: TELAPREVIR-BASED REGIMEN FOR GENOTYPE 1 HEPATITIS C VIRUS INFECTION IN PATIENTS WITH PRIOR NULL RESPONSE, PARTIAL RESPONSE OR RELAPSE TO PEGINTERFERON/RIBAVIRIN

(2011) S. Zeuzem et al.   JOURNAL OF HEPATOLOGY

The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis

(2011) C. Stasi et al.   JOURNAL OF VIRAL HEPATITIS

Prophylactic Antidepressant Treatment in Patients With Hepatitis C on Antiviral Therapy: A Double-Blind, Placebo-Controlled Trial

(2011) Benjamin J. Morasco et al.   PSYCHOSOMATICS

Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C

(2010) Stefano Comai et al.   PHARMACOLOGICAL RESEARCH

Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase

(2010) Luciana Capece et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression

(2009) Arne Schäfer et al.   JOURNAL OF HEPATOLOGY

The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression?

(2009) Joanna K. Soczynska et al.   NEUROTOXICOLOGY

Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter Polymorphism

(2008) Francis E. Lotrich et al.   BIOLOGICAL PSYCHIATRY

Interleukin-1 (IL-1): A central regulator of stress responses

(2008) Inbal Goshen et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Molecular and Bioinformatic Evidence of Hepatitis C Virus Evolution in Brain

(2008) Sarah L. Fishman et al.   JOURNAL OF INFECTIOUS DISEASES

Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1β and tumor necrosis factor-α

(2007) Jennifer M. Loftis et al.   NEUROSCIENCE LETTERS